Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma

Clinical Trial ID NCT01492673

PubWeight™ 4.41‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01492673

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology 2013 1.31
2 Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes. Int J Mol Sci 2015 0.82
3 Targeted therapies for advanced Ewing sarcoma family of tumors. Cancer Treat Rev 2015 0.81
4 Advances in paediatric cancer treatment. Transl Pediatr 2014 0.76
5 Targeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcoma. Clin Sarcoma Res 2016 0.75
Next 100